Egyptian International Pharmaceuticals EIPICO

مادة اعلانية

Latest Update: 21 Nov 2024 16:11 Abu Dhabi Time.

Market Status: Closed

PHAR

Egyptian International Pharmaceuticals EIPICO

47.21

EGP

0.110

0.23%

Open

47.10

Prev Close

47.10

PX_VOLUME

94,802

MARKET CAP (M)

DAY RANGE

47.02 - 47.60

52 WEEKS

32.23 - 54.70

Stock Statistics

Yearly Change

17.75%

Listed Shares (Million)

148.76

Earnings Multiple

6.02

Average 30-day trading volume

620,831.18

Price-to-book ratio

1.46

Earnings Per Share

5.53

Previous Dividend Distribution

Dividend Yield

4.25%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		2,069.94	1,878.96	1,503.10	1,550.58	1,411.12
Gross Profit		924.33	957.12	679.15	633.60	609.06
Operating Income		495.58	550.60	288.63	380.22	353.05
Profit Margin		10.19	9.62	40.51	11.81	9.82

	Period Ending:	Dec 31, 2023	Dec 31, 2022
Total Revenue	5,231.67	3,955.16
Gross Profit	2,335.32	1,653.19
Operating Income	1,312.20	767.92
Profit Margin	16.01	16.55

Balance Sheet

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		14,704.19	13,901.66	13,116.03	9,978.78	9,742.75
Total Liabilities		9,908.59	9,305.30	8,642.93	5,717.98	5,661.10
Total Equity		4,795.61	4,596.35	4,473.10	4,260.80	4,081.64

	Period Ending:	Dec 31, 2023	Dec 31, 2022
Total Assets	9,978.78	6,773.91
Total Liabilities	5,717.98	3,531.52
Total Equity	4,260.80	3,242.39

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

PHAR

Egyptian International Pharmaceuticals EIPICO

المصرية الدولية للصناعات الدوائية